Literature DB >> 27344190

What we have learned about the design of randomized trials in pregnancy.

Elizabeth A Thom1, Madeline Murguia Rice2, George R Saade3, Uma M Reddy4.   

Abstract

For nearly 30 years the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network has been conducting randomized trials in pregnant women, many of which have changed clinical practice. Since 1986, the MFMU Network has conducted 29 randomized trials, of which the 17 trials started or completed since 2003 are described here. Study design choices are described including decisions regarding the fundamental questions to be answered and the rationale behind choices of primary and secondary outcomes. Some of the potential pitfalls, particularly relating to bias, that can affect the interpretation of trial results are described along with the mechanisms that the Network has used to avoid or minimize them.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bias; primary outcome; randomized trial; study design

Mesh:

Year:  2016        PMID: 27344190      PMCID: PMC5080531          DOI: 10.1053/j.semperi.2016.03.011

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  23 in total

1.  Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic.

Authors:  Sara F Goldkind; Leyla Sahin; Beverly Gallauresi
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

2.  17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm.

Authors:  William A Grobman; Elizabeth A Thom; Catherine Y Spong; Jay D Iams; George R Saade; Brian M Mercer; Alan T N Tita; Dwight J Rouse; Yoram Sorokin; Ronald J Wapner; Kenneth J Leveno; Sean Blackwell; M Sean Esplin; Jorge E Tolosa; John M Thorp; Steve N Caritis; J Peter Van Dorsten
Journal:  Am J Obstet Gynecol       Date:  2012-09-17       Impact factor: 8.661

Review 3.  Single versus repeat courses of antenatal steroids to improve neonatal outcomes: risks and benefits.

Authors:  Clarissa Bonanno; Karin Fuchs; Ronald J Wapner
Journal:  Obstet Gynecol Surv       Date:  2007-04       Impact factor: 2.347

4.  Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists' Task Force on Neonatal Encephalopathy.

Authors: 
Journal:  Obstet Gynecol       Date:  2014-04       Impact factor: 7.661

5.  A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study.

Authors:  P Garner; N Okun; E Keely; G Wells; S Perkins; J Sylvain; J Belcher
Journal:  Am J Obstet Gynecol       Date:  1997-07       Impact factor: 8.661

6.  Long-term outcomes after repeat doses of antenatal corticosteroids.

Authors:  Ronald J Wapner; Yoram Sorokin; Lisa Mele; Francee Johnson; Donald J Dudley; Catherine Y Spong; Alan M Peaceman; Kenneth J Leveno; Fergal Malone; Steve N Caritis; Brian Mercer; Margaret Harper; Dwight J Rouse; John M Thorp; Susan Ramin; Marshall W Carpenter; Steven G Gabbe
Journal:  N Engl J Med       Date:  2007-09-20       Impact factor: 91.245

Review 7.  National Institute of Child Health and Human Development (NICHD)-sponsored Perinatal Research Networks.

Authors:  L L Wright; D McNellis
Journal:  Semin Perinatol       Date:  1995-04       Impact factor: 3.300

8.  A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis.

Authors:  Michael A Belfort; George R Saade; Elizabeth Thom; Sean C Blackwell; Uma M Reddy; John M Thorp; Alan T N Tita; Russell S Miller; Alan M Peaceman; David S McKenna; Edward K S Chien; Dwight J Rouse; Ronald S Gibbs; Yasser Y El-Sayed; Yoram Sorokin; Steve N Caritis; J Peter VanDorsten
Journal:  N Engl J Med       Date:  2015-08-13       Impact factor: 91.245

9.  A multicenter, randomized trial of treatment for mild gestational diabetes.

Authors:  Mark B Landon; Catherine Y Spong; Elizabeth Thom; Marshall W Carpenter; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Kristine Y Lain; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa; Garland B Anderson
Journal:  N Engl J Med       Date:  2009-10-01       Impact factor: 91.245

10.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.